LMTK2 | Lemur tyrosine kinase 2 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
LPCAT1 | Lysophosphatidylcholine acyltransferase 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
LPCAT2 | Lysophosphatidylcholine acyltransferase 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
LRRK1 | Leucine-rich repeat kinase 1 | Enzymes
| | | | | Mixed |
MAP2K1 | Mitogen-activated protein kinase kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
MAP2K2 | Mitogen-activated protein kinase kinase 2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
MAP2K6 | Mitogen-activated protein kinase kinase 6 | Cytoskeleton related proteins Enzymes
| | | | | Expressed in all |
MAP3K2 | Mitogen-activated protein kinase kinase kinase 2 | Enzymes
| | | | | Expressed in all |
MAP3K7 | Mitogen-activated protein kinase kinase kinase 7 | Enzymes
| | | | | Expressed in all |
MAP3K8 | Mitogen-activated protein kinase kinase kinase 8 | Enzymes Plasma proteins
| | | | | Expressed in all |
MAP3K9 | Mitogen-activated protein kinase kinase kinase 9 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Mixed |
MAP4K5 | Mitogen-activated protein kinase kinase kinase kinase 5 | Enzymes
| | | | | Expressed in all |
MAPK1 | Mitogen-activated protein kinase 1 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets Plasma proteins RAS pathway related proteins
| | | | | Expressed in all |
MAPK12 | Mitogen-activated protein kinase 12 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Tissue enriched |
MAPK14 | Mitogen-activated protein kinase 14 | Cancer-related genes Enzymes
| | | | | Expressed in all |
MAPK3 | Mitogen-activated protein kinase 3 | Cancer-related genes Cytoskeleton related proteins Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
MAPK6 | Mitogen-activated protein kinase 6 | Enzymes
| | | | | Expressed in all |
MAPK7 | Mitogen-activated protein kinase 7 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
MAPKAPK2 | Mitogen-activated protein kinase-activated protein kinase 2 | Cancer-related genes Enzymes Predicted membrane proteins
| | | | | Expressed in all |
MAPKAPK3 | Mitogen-activated protein kinase-activated protein kinase 3 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
MAPKAPK5 | Mitogen-activated protein kinase-activated protein kinase 5 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
MAST2 | Microtubule associated serine/threonine kinase 2 | Cancer-related genes Enzymes Predicted membrane proteins
| | | | | Expressed in all |
MASTL | Microtubule associated serine/threonine kinase-like | Disease related genes Enzymes Potential drug targets
| | | | | Mixed |
MET | Met proto-oncogene | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
METTL1 | Methyltransferase like 1 | Enzymes Plasma proteins
| | | | | Expressed in all |
METTL14 | Methyltransferase like 14 | Cancer-related genes Enzymes
| | | | | Expressed in all |
MGAT2 | Mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Mixed |
MGMT | O-6-methylguanine-DNA methyltransferase | Cancer-related genes Enzymes
| | | | | Expressed in all |
MKNK2 | MAP kinase interacting serine/threonine kinase 2 | Enzymes
| | | | | Expressed in all |
MLTK | Mitogen-activated protein kinase kinase kinase MLT | Enzymes
| | | | | Expressed in all |
MOCS2 | Molybdenum cofactor synthesis 2 | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
MST4 | Serine/threonine-protein kinase MST4 | Enzymes
| | | | | Mixed |
MTAP | Methylthioadenosine phosphorylase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
MTPAP | Mitochondrial poly(A) polymerase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
MTR | 5-methyltetrahydrofolate-homocysteine methyltransferase | Disease related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Expressed in all |
MYLK | Myosin light chain kinase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
NAA10 | N(alpha)-acetyltransferase 10, NatA catalytic subunit | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
NAA20 | N(alpha)-acetyltransferase 20, NatB catalytic subunit | Enzymes
| | | | | Expressed in all |
NAA30 | N(alpha)-acetyltransferase 30, NatC catalytic subunit | Enzymes
| | | | | Expressed in all |
NAGK | N-acetylglucosamine kinase | Enzymes
| | | | | Expressed in all |
NANS | N-acetylneuraminic acid synthase | Enzymes
| | | | | Expressed in all |
NAT8L | N-acetyltransferase 8-like (GCN5-related, putative) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
NCOA3 | Nuclear receptor coactivator 3 | Cancer-related genes Enzymes Plasma proteins Transcription factors
| | | | | Expressed in all |
NEK11 | NIMA-related kinase 11 | Enzymes
| | | | | Tissue enhanced |
NEK2 | NIMA-related kinase 2 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enriched |
NEK7 | NIMA-related kinase 7 | Enzymes
| | | | | Expressed in all |
NFS1 | NFS1 cysteine desulfurase | Enzymes Mitochondrial proteins
| | | | | Expressed in all |
NLK | Nemo-like kinase | Enzymes
| | | | | Expressed in all |
NMT1 | N-myristoyltransferase 1 | Enzymes
| | | | | Expressed in all |
NMT2 | N-myristoyltransferase 2 | Enzymes
| | | | | Expressed in all |